Related references
Note: Only part of the references are listed.Lower ototoxicity and absence of hidden hearing loss point to gentamicin C1a and apramycin as promising antibiotics for clinical use
Masaaki Ishikawa et al.
SCIENTIFIC REPORTS (2019)
In vitro activity of apramycin against multidrug-, carbapenem- and aminoglycoside-resistant Enterobacteriaceae and Acinetobacter baumannii
Mario Juhas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)
MIC-based dose adjustment: facts and fables
Johan W. Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Semi-mechanistic pharmacokinetic-pharmacodynamic modelling of antibiotic drug combinations
M. J. E. Brill et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Variation of MIC measurements: the contribution of strain and laboratory variability to measurement precision
Johan W. Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
Can a pharmacokinetic/pharmacodynamic (PKPD) model be predictive across bacterial densities and strains? External evaluation of a PKPD model describing longitudinal in vitro data
Elisabet I. Nielsen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
In vitro Apramycin Activity against multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa
Anthony D. Kang et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae
Kenneth P. Smith et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
A pharmacokinetic-pharmacodynamic (PKPD) model based on in vitro time-kill data predicts the in vivo PK/PD index of colistin
David D. Khan et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Simulation-Based Evaluation of PK/PD Indices for Meropenem Across Patient Groups and Experimental Designs
Anders N. Kristoffersson et al.
PHARMACEUTICAL RESEARCH (2016)
Adaptive resistance to antibiotics in bacteria: a systems biology perspective
Santiago Sandoval-Motta et al.
WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE (2016)
Aminoglycosides: An Overview
Kevin M. Krause et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Once-daily aminoglycoside dosing: An update on current literature
Matthew S. Stankowicz et al.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2015)
Optimization of human dose prediction by using quantitative and translational pharmacology in drug discovery
Tjerk Bueters et al.
FUTURE MEDICINAL CHEMISTRY (2015)
A Proposal of a Pharmacokinetic/pharmacodynamic (PK/PD) Index Map for Selecting an Optimal PK/PD Index from Conventional Indices (AUC/MIC, Cmax/MIC, and TAM) for Antibiotics
Yoshiaki Kitamura et al.
DRUG METABOLISM AND PHARMACOKINETICS (2014)
Interspecies Pharmacokinetics. 1. Allometric Scaling of Pharmacokinetic Parameters (a Review)
O. V. Polekhina et al.
PHARMACEUTICAL CHEMISTRY JOURNAL (2014)
Population Pharmacokinetics of Inhaled Tobramycin Powder in Cystic Fibrosis Patients
L. Ting et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
Pharmacokinetic-Pharmacodynamic Modeling of Antibacterial Drugs
Elisabet I. Nielsen et al.
PHARMACOLOGICAL REVIEWS (2013)
Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and Xpose
R. J. Keizer et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2013)
Applications of Human Pharmacokinetic Prediction in First-in-Human Dose Estimation
Peng Zou et al.
AAPS JOURNAL (2012)
Pharmacokinetic-Pharmacodynamic Model for Gentamicin and Its Adaptive Resistance with Predictions of Dosing Schedules in Newborn Infants
Ami F. Mohamed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Exogenously acquired 16S rRNA methyltransferases found in aminoglycoside-resistant pathogenic Gram-negative bacteria: An update
Jun-ichi Wachino et al.
DRUG RESISTANCE UPDATES (2012)
Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin
Tanja Matt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization
Elisabet I. Nielsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Optimizing Aminoglycoside Use
William A. Craig
CRITICAL CARE CLINICS (2011)
Prediction of Human Renal Clearance from Preclinical Species for a Diverse Set of Drugs That Exhibit Both Active Secretion and Net Reabsorption
Stuart W. Paine et al.
DRUG METABOLISM AND DISPOSITION (2011)
Creeping baselines and adaptive resistance to antibiotics
Lucia Fernandez et al.
DRUG RESISTANCE UPDATES (2011)
Interspecies scaling and prediction of human clearance: comparison of small- and macro-molecule drugs
Yeamin Huh et al.
XENOBIOTICA (2011)
Antibiotics that target protein synthesis
Lisa S. McCoy et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2011)
Mechanistic Basis of Using Body Size and Maturation to Predict Clearance in Humans
Brian J. Anderson et al.
DRUG METABOLISM AND PHARMACOKINETICS (2009)
On the anticipation of the human dose in first-in-man trials from preclinical and prior clinical information in early drug development
P. J. Lowe et al.
XENOBIOTICA (2007)
Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments
Elisabet I. Nielsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
PsN-Toolkit - A collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM
L Lindbom et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2005)
Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update
JW Mouton et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Population pharmacokinetics of gentamicin in hospitalized patients receiving once-daily dosing
DW Xuan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Ways to fit a PK model with some data below the quantification limit
SL Beal
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2001)
Share Paper
